T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides

2007 ◽  
Vol 57 (5) ◽  
pp. 782-790 ◽  
Author(s):  
Stacy E. Thurber ◽  
Bing Zhang ◽  
Youn H. Kim ◽  
Iris Schrijver ◽  
James Zehnder ◽  
...  
Dermatology ◽  
2019 ◽  
Vol 236 (2) ◽  
pp. 117-122 ◽  
Author(s):  
Roberta Vasconcelos Berg ◽  
Neusa Yuriko Sakai Valente ◽  
Camilla Fanelli ◽  
Isabelle Wu ◽  
Juliana Pereira ◽  
...  

Background: Poikilodermatous mycosis fungoides (pMF) is characterized by poikiloderma areas, typically involving the major flexural areas and trunk. Its presentation can be generalized or admixed with other forms of MF. Previous studies fail to correlate the clinical presentation with prognosis and laboratory findings. Some reports show pityriasis lichenoides chronica (PLC) preceding the poikiloderma. Objectives: Correlate prognostic, histopathological and molecular aspects of pMF with its clinical presentation. Methods: Retrospective analysis of 14 cases of generalized pMF (GpMF), 22 of localized pMF (LpMF) and 17 of pMF admixed with other forms of MF (mix-pMF). Results: Female predominance and lower age at diagnosis was found in all groups compared to classic MF, a high prevalence of PLC-like lesions in the GpMF group and a high rate of hypopigmented lesions in the mix-pMF group. There were 2 deaths within the GpMF group. Histology was similar to previously reported findings, as was the prevalence of CD4 T-cell infiltrate, compared to CD8. The T-cell clonality positivity was lower in the GpMF group, compared to other groups (27% GpMF, 80% LpMF and 100% mix-pMF). Discussion: This is the first article to categorize the different forms of pMF and correlate them with clinical and laboratory findings. The dermatological presentation differs among the groups. There was a high frequency of PLC-like lesions within the GpMF group and of hypopigmented lesions in mix-pMF. The histological and immunohistochemical findings were similar to those previously reported. Aggressive treatments are not recommended due to the good prognosis of all pMF forms. The low positivity of T-cell clonality in the GpMF group should be investigated.


2003 ◽  
Vol 12 (3) ◽  
pp. 142-150 ◽  
Author(s):  
J. Marcus Muche ◽  
Wolfram Sterry ◽  
Sylke Gellrich ◽  
Berthold Rzany ◽  
Heike Audring ◽  
...  

2015 ◽  
Vol 73 (2) ◽  
pp. 228-236.e2 ◽  
Author(s):  
Kari E. Sufficool ◽  
Christina M. Lockwood ◽  
Haley J. Abel ◽  
Ian S. Hagemann ◽  
Jonathan A. Schumacher ◽  
...  

2008 ◽  
Vol 159 (4) ◽  
pp. 881-886 ◽  
Author(s):  
C. Massone ◽  
G. Crisman ◽  
H. Kerl ◽  
L. Cerroni

Blood ◽  
2005 ◽  
Vol 105 (2) ◽  
pp. 503-510 ◽  
Author(s):  
Chalid Assaf ◽  
Michael Hummel ◽  
Matthias Steinhoff ◽  
Christoph C. Geilen ◽  
Helmut Orawa ◽  
...  

AbstractThe lymph nodes are generally the first extracutaneous manifestation in patients with cutaneous T-cell lymphoma (CTCL); however, their early involvement is difficult to assess. The aim of our study was to define the diagnostic and prognostic value of T-cell clonality analysis for a more precise assessment of lymph node involvement in CTCL. T-cell clonality was determined by 2 independent polymerase chain reaction (PCR) assays, namely a recently developed T-cell receptor-β (TCR-β) PCR technique as well as an established TCR-γ PCR. T-cell clonality was found in 22 of 22 lymph nodes with histologically detectable CTCL involvement as well as in 7 of 14 histologically noninvolved dermatopathic lymph nodes. The clonal T-cell populations in the lymph nodes were in all cases identical to those detected in the corresponding skin lesions, identifying them as the tumor cell population. T-cell clonality was not found in any of the 12 dermatopathic lymph nodes from 12 patients with inflammatory skin diseases. Clonal T-cell detection in 7 of 14 dermatopathic lymph nodes of patients with CTCL was associated with limited survival (74 months; confidence interval [CI], 66-82 months) as in patients with histologically confirmed lymph node involvement (41 months; CI, 35-47 months), whereas all patients without T-cell clonality in the lymph nodes (7 patients) were alive at the last follow-up. Thus, T-cell clonality analysis is an important adjunct in differentiating benign dermatopathic lymphadenitis from early CTCL involvement.


2000 ◽  
Vol 115 (3) ◽  
pp. 504-505 ◽  
Author(s):  
J. Marcus Muche ◽  
Ansgar Lukowsky ◽  
Cordula Ahnhudt ◽  
Sylke Gellrich ◽  
Wolfram Sterry

Sign in / Sign up

Export Citation Format

Share Document